Skip to content

Transcranial Magnetic Stimulation in Children With Stroke

Transcranial Magnetic Stimulation in Children With Stroke

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01637129
Acronym
TMSCS
Enrollment
4
Registered
2012-07-10
Start date
2012-05-31
Completion date
2013-08-31
Last updated
2014-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiparesis, Neonatal Stroke, Ischemic Stroke, Hemorrhagic Stroke, Thrombotic Stroke

Keywords

Childhood stroke, Perinatal stroke, Pediatric stroke, Presumed perinatal stroke, Children who have hemiparesis

Brief summary

This is a pilot study of repetitive transcranial magnetic stimulation (rTMS) to test tolerance and efficacy in children who have hemiparesis from acquired or presumed perinatal stroke.

Detailed description

The investigators will begin to test the hypothesis that rTMS will be tolerated and will result in improved hand strength and mobility when compared with sham stimulation. Aim 1: To determine whether 1 Hz rTMS applied to the hemisphere opposite the infarct (contralesional or healthy hemisphere) is tolerated by children ages 6-18 years who have chronic motor sequelae from a stroke. Aim 2: To determine whether 8 sessions of inhibitory 1 Hz rTMS to the contralesional healthy hemisphere improves grip strength and hand mobility when compared with sham stimulation in controls.

Interventions

DEVICETranscranial Magnetic Stimulation

Transcranial Magnetic Stimulation, repetitive at 1Hz

Sham Magnetic Stimulation

Sponsors

Ohio State University
CollaboratorOTHER
Nationwide Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

1. A history of ischemic or hemorrhagic stroke at least 6 months prior to recruitment, and causing current unilateral motor impairment of hand function (scoring 1-3 on a modified Ashworth scale; scale explained in Appendix). 2. Cerebral infarction spares the transcallosal pathways. 3. Cerebral injury confirmed by brain MRI or CT 4. Ages 6-18 years inclusive.

Exclusion criteria

1. The presence of an implanted device such as a pacemaker, vagal nerve stimulator, or recently implanted cardiovascular stent; arterial aneurysms; arteriovenous malformations; obstructive hydrocephalus. 2. Infarction of the cortical motor areas. 3. Presence of a brain tumor or suspected neurodegenerative disease. 4. Intractable epilepsy or a history of poorly controlled epilepsy. 5. Current use of medications that may lower seizure threshold (such as specific antipsychotics, specific antidepressants, amphetamines) 6. Hand function limited to rigid flexion or extension (score = 4 on the modified Ashworth scale) 7. Disorders causing hallucinations, delusions, or excessive anxiety or depression. 8. Pre-existing chronic pain syndromes including intractable headache and chronic daily headache. 9. Pregnancy. 10. Any sensorimotor or cognitive impairment that prevents valid responses on study measures. 11. Bilateral strokes (cerebral injuries) involving motor cortex and/or corpus callosum 12. All patients and parents must be naïve regarding the effects and sensations of rTMS (i.e., patients and/or parents with prior exposure to TMS will be excluded). 13. Subject has had a recent neurosurgical procedure involving the brain. 14. Subject suffered traumatic brain injury that places the subject at risk of seizures.

Design outcomes

Primary

MeasureTime frameDescription
Tolerance to repetitive stimulationUp to 2 daysThe patient's reports of side effects recorded on the CRF at each session will be tabulated and the pre-stimulation scores will be subtracted from the post-stimulation scores. Cognitive function will be assessed with 6 measures (Executive Function / Spatial Problem Solving, Psychomotor Function / Speed of Processing, Visual Attention / Vigilance, Visual Learning & Memory, Verbal Learning & Memory, and Attention / Working Memory measures). As with the tolerance assessments, we will tabulate before-stimulation and after-stimulation assessments and analyze the difference.

Secondary

MeasureTime frameDescription
Upper extremity strength and mobilityUp to 2 MonthsUpper extremity strength will be assessed with a Jtech dynamometer at three different locations: elbow extension (triceps), elbow flexion (biceps), and grip. Joint mobility at the elbow and wrist will be assessed with the modified Ashworth score.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026